Suggestions
Michelle Haven
Anterra Capital
Professional Background
Michelle Haven is an accomplished professional in the fields of physiology and pathology, with a career spanning several prominent roles in the pharmaceutical and animal health industries. Her extensive experience includes leadership positions at notable companies, establishing her as a senior advisor and venture partner at Anterra Capital. In her role at Anterra Capital, she leverages her expertise to guide investment strategies and partnerships that foster innovation in agriculture and animal health sectors.
Prior to her current position, Michelle made significant contributions to Zoetis Inc. as the Senior Vice President of Business Development, Alliances, and Solutions. In this role, she demonstrated her expertise in forging strategic alliances and driving business growth through innovative solutions tailored to the animal health marketplace. Her tenure at Zoetis highlighted her ability to build collaborative relationships and create value across the organization.
Before joining Zoetis, Michelle served as the Vice President of Business Development and Global Alliances at Pfizer, where she was instrumental in identifying new opportunities for growth and innovation. Her insight into market trends and ability to develop strategic partnerships made her a key player in Pfizer's endeavors in the animal health division.
Michelle's journey in the pharmaceutical and biological research domain gained momentum during her time as Executive Director for Global Pharmaceutical and Biologicals Research at Pfizer Animal Health. Here, she led groundbreaking research initiatives that aimed to improve animal health and welfare through scientific innovation. Her leadership was pivotal in guiding research teams to achieve significant milestones in pharmaceutical development for animals.
Furthermore, Michelle has a rich background in pharmaceutical discovery, having served as the Director of Animal Health Pharmaceutical Discovery at Pfizer. Her focus on integrating scientific research with commercial strategies paved the way for the translation of scientific discoveries into viable products that address critical health needs in the animal sector.
Michelle's career took off at Merck, where she started as a Research Fellow. During her tenure, she was involved in pivotal research that contributed to the understanding of various pharmaceutical advancements.
Education and Achievements
Michelle's academic foundation is equally impressive, having received her Bachelor of Science degree in Veterinary Medicine (DVM) from the University of Illinois at Urbana-Champaign. This rigorous education laid the groundwork for her profound understanding of animal health and medicine. Following her undergraduate studies, Michelle pursued a PhD in Physiology and Pathology at North Carolina State University, deepening her knowledge of biological processes and disease mechanisms. Her strong educational background complements her extensive professional experience, allowing her to approach challenges in the animal health and pharmaceutical industries with both scientific acumen and strategic insight.
Throughout her career, Michelle has been recognized for her innovative thinking and leadership qualities. Her ability to guide teams and foster collaborations has been central to her success, making her a sought-after expert in her fields of specialization. Michelle is known for her forward-thinking approach and the capacity to navigate complex environments within the pharmaceutical landscape. Her contributions to research and development have played a crucial role in advancing animal health and pharmaceutical solutions.
Achievements
Michelle has achieved numerous accolades and recognition throughout her career, reflecting her commitment to excellence in the animal health and pharmaceutical industries. She is often sought for her insights and strategies in business development and innovation, energizing teams to perform at the highest levels. Michelle's success story is marked by her capability to translate complex scientific knowledge into actionable business strategies, reinforcing her status as a leader in the industry.
